Authored By: Sarah
10 Mar 2021

Neurostimulation Devices Market Size to Grow by $ 2.23 bn through 2021-2025  

Technavio research projects the neurostimulation devices market to grow by $ 2.23 bn, accelerating at a CAGR of about 8% till 2025. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking


Neurostimulation Devices Market: Receive FREE Sample Report


Neurostimulation Devices Market: Key Market Driver

One of the primary factors that will trigger the growth of the neurostimulation devices market size is Rising prevalence of neurological disorders. This research report provides a comprehensive analysis of all the factors that are likely to propel market growth, taking into account the market trends as well as challenges that are likely to impede growth. The objective of this research report is to equip clients with actionable insights that will help them leverage opportunities and formulate growth strategies for their business.

Neurostimulation Devices Market Size to Grow by Over $ 2.2 Billion in 2021-2025  

Neurostimulation Devices Market: Vendor Analysis

The market is concentrated due to the presence of several players. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Axonics Modulation Technologies Inc., Bioness Inc., LivaNova Plc, Medtronic Plc, NeuroMetrix Inc., NEURONETICS INC, NeuroSigma Inc. , Nexstim Plc, and Nuvectra Medical are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

Technavio also offers custom research reports with detailed insights assessing the market from a global as well as regional perspective. This customized report will help clients keep up with new product launches in direct & indirect or related markets. It will also provide insights on upcoming developments along with a pipeline analysis of vendor operations and the impact of government regulations.

For more insights on this market: Download a Free Sample Report

Technavio has been monitoring the global neurostimulation devices market and it is expected to grow by $ 2.23 billion, accelerating at a CAGR of about 8% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking. View Free Sample Report

Neurostimulation Devices Market: Segmentation by Product

The implantable neurostimulation devices segment will account for the highest market share of the neurostimulation devices market. This report provides an accurate prediction of the contribution of all the segments to the growth of the neurostimulation devices market size.

Neurostimulation Devices Market Size to Grow by Over $ 2.2 Billion in 2021-2025  

Neurostimulation Devices Market: Segmentation by Geography

Europe was the largest Neurostimulation Devices Market in 2020, and the region will offer several growth opportunities to market vendors during the forecast period. 37% of the market growth will originate from Europe during the forecast period. Germany, France, and UK are the key markets for the neurostimulation devices market in Europe. However, market growth in this region will be slower than the growth of the market in APAC. The access to advanced neurostimulation devices and high prevalence of neurological disorders will facilitate the neurostimulation devices market growth in Europe over the forecast period. 

Neurostimulation Devices Market: Vendor Analysis

Neurostimulation Devices Market Size to Grow by Over $ 2.2 Billion in 2021-2025  

The market is concentrated. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, Axonics Modulation Technologies Inc. and Bioness Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

Technavio offers custom research reports with detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations.

For more insights on this market: Download a Free Sample Report 

Read News Read Less
Interested in this report?
Get your sample now!
Technavio